| 1 |
24374792 | A mitochondrial basis for Huntington's disease: therapeutic prospects. | 2014 Apr |
1 |
| 2 |
24603212 | Mechanisms of synaptic dysfunction and excitotoxicity in Huntington's disease. | 2014 Jul |
1 |
| 3 |
22334892 | A novel target for Huntington's disease: ERK at the crossroads of signaling. The ERK signaling pathway is implicated in Huntington's disease and its upregulation ameliorates pathology. | 2012 Feb |
1 |
| 4 |
22905336 | Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington's disease: interactions between neurons and astrocytes. | 2012 Jul 1 |
2 |
| 5 |
21153060 | Huntington's disease and Group I metabotropic glutamate receptors. | 2011 Feb |
1 |
| 6 |
20644995 | Effects of mutant huntingtin on mGluR5-mediated dual signaling pathways: implications for therapeutic interventions. | 2010 Oct |
2 |
| 7 |
18829967 | Dopaminergic and glutamatergic signaling crosstalk in Huntington's disease neurodegeneration: the role of p25/cyclin-dependent kinase 5. | 2008 Oct 1 |
1 |
| 8 |
12200414 | Calcium-dependent cleavage of endogenous wild-type huntingtin in primary cortical neurons. | 2002 Oct 18 |
1 |
| 9 |
11319238 | Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-D-aspartate receptors via post-synaptic density 95. | 2001 Jul 6 |
3 |